According to the new update on their site, the Mayo Clinic now states that "Hydroxychloroquine may be used to treat coronavirus (COVID-19) in certain hospitalized patients."
This marks a departure from their previous stance, in which the Mayo Clinic had described Hydroxychloroquine and chloroquine as "malaria drugs authorized for emergency use by the FDA during the COVID-19 pandemic." However, the FDA later withdrew that authorization after data analysis revealed that these drugs were not effective in treating COVID-19.
September 25, 2023
The Mayo Clinic's change in position is noteworthy, as it suggests that there may be a potential role for Hydroxychloroquine in the treatment of COVID-19, albeit in specific hospitalized patients. This update could have implications for the ongoing debate surrounding the use of this drug.
MUST WATCH: GIANT EMPEROR TRUMP FIGURE AT ITALIAN FESTIVAL
In the past, Hydroxychloroquine gained significant attention when President Trump announced that he had taken it after testing positive for COVID-19. However, this decision was met with criticism from some medical professionals, including Dr. Michael Ackerman, a cardiologist from the Mayo Clinic. Dr. Ackerman expressed concern that President Trump did not mention the potential side effects of Hydroxychloroquine.
UNIVERSITY OF WASHINGTON SET TO ESTABLISH "GAZA CAMP" AFTER BEING DENIED FOR LACK OF LEADERSHIP
September 25, 2023
Interestingly, Dr. Ackerman's perspective on COVID-19 vaccines and their alleged link to the deaths of young athletes differs. He dismissed such claims as "junk science," highlighting the importance of evidence-based research in understanding the impact of vaccines on various populations.
Discover alternative ideas that will make you think
Engage in mind bending debate
Earn points, rise in rank, have fun
